Cavendish Impact Capital manages a suite of Impact Capital Funds designed to allocate critical capital resources toward early-stage companies in the healthcare, pharmaceutical, and medical device sectors. The firm aims to balance the pursuit of high returns with a positive impact on society through its investments.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions